Literature DB >> 21180613

The bacterial pathogenesis and treatment of pouchitis.

S D McLaughlin1, S K Clark, P P Tekkis, R J Nicholls, P J Ciclitira.   

Abstract

Restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis is the operation of choice for patients with ulcerative colitis. Pouchitis is the most common cause of pouch dysfunction. Although the pathogenesis of this disease is not well understood, bacteria have been implicated in the disease process. Numerous bacterial studies have been reported over the last 25 years with few unifying findings. In addition, many different treatments for pouchitis have been reported with varying results. Antibiotic treatment remains the most studied and is the mainstay of treatment. In this article we review the aetiology of pouchitis and the evidenced-based treatment options.

Entities:  

Keywords:  dysbiosis; familial adenomatous polyposis; ileal pouch-anal anastomosis; inflammatory bowel disease; pouchitis; restorative proctocolectomy; ulcerative colitis

Year:  2010        PMID: 21180613      PMCID: PMC3002591          DOI: 10.1177/1756283X10370611

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  95 in total

1.  Cytomegalovirus infection as a cause of ileoanal pouchitis.

Authors:  P R Pfau; G R Lichtenstein
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

2.  Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study.

Authors:  M Joelsson; M Andersson; T Bark; K Gullberg; T Hallgren; H Jiborn; I Magnusson; Y Raab; R Sjödahl; B Ojerskog; T Oresland
Journal:  Scand J Gastroenterol       Date:  2001-11       Impact factor: 2.423

3.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

4.  Altered expression of the lymphocyte activation markers CD30 and CD27 in patients with pouchitis.

Authors:  P D Thomas; A Forbes; R J Nicholls; P J Ciclitira
Journal:  Scand J Gastroenterol       Date:  2001-03       Impact factor: 2.423

5.  Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

Authors:  A Suau; R Bonnet; M Sutren; J J Godon; G R Gibson; M D Collins; J Doré
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

6.  A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.

Authors:  B Shen; J P Achkar; B A Lashner; A H Ormsby; F H Remzi; A Brzezinski; C L Bevins; M L Bambrick; D L Seidner; V W Fazio
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

7.  Morbidity and functional outcome after restorative proctocolectomy for ulcerative colitis.

Authors:  E Johnson; E Carlsen; M Nazir; K Nygaard
Journal:  Eur J Surg       Date:  2001-01

8.  Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome.

Authors:  T E Madiba; D C Bartolo
Journal:  J R Coll Surg Edinb       Date:  2001-12

9.  Ileoanal pouch operation: long-term outcome with or without diverting ileostomy.

Authors:  P M Mowschenson; J F Critchlow; M A Peppercorn
Journal:  Arch Surg       Date:  2000-04

10.  Comparison of postoperative outcomes in ulcerative colitis and familial polyposis patients after ileoanal pouch operations.

Authors:  J G Barton; M A Paden; M Lane; R G Postier
Journal:  Am J Surg       Date:  2001-12       Impact factor: 2.565

View more
  13 in total

1.  Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.

Authors:  Mireia Lopez-Siles; Margarita Martinez-Medina; Carles Abellà; David Busquets; Miriam Sabat-Mir; Sylvia H Duncan; Xavier Aldeguer; Harry J Flint; L Jesús Garcia-Gil
Journal:  Appl Environ Microbiol       Date:  2015-08-21       Impact factor: 4.792

Review 2.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.

Authors:  Mireia Lopez-Siles; Sylvia H Duncan; L Jesús Garcia-Gil; Margarita Martinez-Medina
Journal:  ISME J       Date:  2017-01-03       Impact factor: 10.302

Review 3.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 4.  Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.

Authors:  Jessica Soldavini; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2013-07-10       Impact factor: 3.199

Review 5.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

6.  Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation.

Authors:  Sidhartha R Sinha; Yeneneh Haileselassie; Linh P Nguyen; Carolina Tropini; Min Wang; Laren S Becker; Davis Sim; Karolin Jarr; Estelle T Spear; Gulshan Singh; Hong Namkoong; Kyle Bittinger; Michael A Fischbach; Justin L Sonnenburg; Aida Habtezion
Journal:  Cell Host Microbe       Date:  2020-02-25       Impact factor: 21.023

7.  Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease.

Authors:  Xochitl C Morgan; Boyko Kabakchiev; Levi Waldron; Andrea D Tyler; Timothy L Tickle; Raquel Milgrom; Joanne M Stempak; Dirk Gevers; Ramnik J Xavier; Mark S Silverberg; Curtis Huttenhower
Journal:  Genome Biol       Date:  2015-04-08       Impact factor: 13.583

8.  Integrating host gene expression and the microbiome to explore disease pathogenesis.

Authors:  Allyson L Byrd; Julia A Segre
Journal:  Genome Biol       Date:  2015-04-08       Impact factor: 13.583

9.  NOD2 Genetic Variants Predispose One of Two Familial Adenomatous Polyposis Siblings to Pouchitis Through Microbiome Dysbiosis.

Authors:  Kathleen M Schieffer; Justin R Wright; Leonard R Harris; Sue Deiling; Zhaohai Yang; Regina Lamendella; Gregory S Yochum; Walter A Koltun
Journal:  J Crohns Colitis       Date:  2017-10-27       Impact factor: 9.071

10.  Geriatric Respondents and Non-Respondents to Probiotic Intervention Can be Differentiated by Inherent Gut Microbiome Composition.

Authors:  Suja Senan; Jashbhai B Prajapati; Chaitanya G Joshi; V Sreeja; Manisha K Gohel; Sunil Trivedi; Rupal M Patel; Himanshu Pandya; Uday Shankar Singh; Ajay Phatak; Hasmukh A Patel
Journal:  Front Microbiol       Date:  2015-09-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.